INTRODUCTION

Clinical pharmacy provides a platform to perform activities through which pharmacist cooperates and coordinates with other health professionals in designing, implementing and monitoring a therapeutic care plan in order to give better care to patients evaluation and review of drug utilization process. It provides understanding regarding Therapeutic Drug monitoring of different Drugs. It plays a critical role in understanding of different drug interactions like drug-drug, drug-food, drug-lab and drug-disease interactions. The subject enables students to find and manage drug induced diseases and their management.  The students will also have an insight of role of computers in e-prescription, clinical trials, clinical research and data management in different clinical settings. The students will gain a competency regarding how to write and how to evaluate drug literatures.  Students will learn the practical skills of taking patient’s history, dose calculation for pediatric patients and establish drug information resources & toxicology

CORURSE OUTLINE

Course Tittle: PHARMACY PRACTICE-VIB(ADVANCED CLINICAL PHARMACY)

Course Code: Phrm-506

Semester : 10th

Credit Hours:10

INTENDED LEARNING OUTCOMES

At the end of this course, students will have a better understanding of clinical pharmacy, its scope and practice. They will be able to communicate with the patients in an effective way. Moreover, they would be able to collect and analyze case studies of various patients.

CONTENTS

1. PHARMACEUTICAL CARE, ITS SCOPE, MANAGEMENT AND APPLICATIONS:
2. CLINICAL THERAPEUTICS: General Strategy: Terminology of Disease. Management and treatment. Drug selection.
3. DISEASE MANAGEMENT:  Unit VIII : Oncology Unit ( Types of tumors, Introduction to Oncological diseases e.g., Prostate cancer, Breast cancer, Lungs cancer)  Unit IX: Nephrology Unit (Renal failure, nephrotic syndrome)
4. CLINICAL TOXICOLOGY: a. General information. Role of pharmacist in treatment of poisoning and general management of poisoning & over dosage. Role and status of Poison Control Centre. b. Antidotes and their mechanism of action.
5. SAFE INTRAVENOUS THERAPY & HAZARDS OF I.V. THERAPY:
6. : Definition, introduction and importance, Extent of non-compliance, Methods of assessment, Reasons for non-compliance, Strategies for improving compliance.

READINGS

1. DiPiro JT. Encyclopedia of Clinical Pharmacy. 1st Ed. Informa Healthcare; 2002.

2. Gennaro AR. Remington: The science and practice of pharmacy. 21st Ed. Lippincott

     Williams & Wilkins; 2011.

3. Gourley H. Clinical Pharmacy & Therapeutics. 4th Ed. William&Willkins; 1992.

4. Hansten P, Horn J. Drug interactions Analysis and Management. 5th Ed. Lippincott

    Williams & Wilkins; 2010.

5. Koda-Kimble MA, Young LY, Kradjan WA, Guglielmo BJ, Alldredge BK, Corelli RL. Applied

    therapeutics: the clinical use of drugs. Lippincott Williams & Wilkins Baltimore; 2005.

6. Poisoning and drug overdose by the faculty, staff associates of California poisoning control

      system edited by Kent R Olson Lange clinical manual

7. Sweetman S. Martindale: The complete drug reference. 37th Ed. Pharmaceutical Press.

      2011.

8. Walker R. Clinical Pharmacy & Therapeutics. 4th Ed. Churchill Levingstone; 2003.

9. Winfield AJ, Rees J, SmithI.Pharmaceutical practice. 4th Ed. Churchill Livingstone; 2009.

10. Zinc G. Comprehensive Pharmacy ReviewPhiladelphiaCollege of

      Pharmacy and Science: New York 1157; 2005

COURSE SCHEDULE

RESEARCH PROJECT

• Advanced Clinical Pharmacy Based Research Projects

ASSESSMENT CRITERIA

Sessional: 20% (Ward rounds and clinical case studies)

Mid exam: 30% 

Final exam: 50%

RULESANDREGULATIONS

Following are the rules and regulations that students have to abide by in my class

• Class attendance. (80% class attendance)
• Study of course materials as specified by the instructor
• Completion of given task on time